- Home
- CUE vs GRWG Comparison
CUE vs GRWG Comparison
Compare CUE & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- GRWG
- Stock Information
- Founded
- CUE 2014
- GRWG 2008
- Country
- CUE United States
- GRWG United States
- Employees
- CUE N/A
- GRWG N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- CUE Health Care
- GRWG Consumer Discretionary
- Exchange
- CUE Nasdaq
- GRWG Nasdaq
- Market Cap
- CUE 91.9M
- GRWG 82.3M
- IPO Year
- CUE 2018
- GRWG N/A
- Fundamental
- Price
- CUE $1.28
- GRWG $1.50
- Analyst Decision
- CUE Strong Buy
- GRWG Hold
- Analyst Count
- CUE 5
- GRWG 5
- Target Price
- CUE $5.00
- GRWG $2.75
- AVG Volume (30 Days)
- CUE 283.2K
- GRWG 633.8K
- Earning Date
- CUE 03-10-2025
- GRWG 03-12-2025
- Dividend Yield
- CUE N/A
- GRWG N/A
- EPS Growth
- CUE N/A
- GRWG N/A
- EPS
- CUE N/A
- GRWG N/A
- Revenue
- CUE $9,532,000.00
- GRWG $200,882,000.00
- Revenue This Year
- CUE $73.11
- GRWG N/A
- Revenue Next Year
- CUE $11.02
- GRWG N/A
- P/E Ratio
- CUE N/A
- GRWG N/A
- Revenue Growth
- CUE 149.53
- GRWG N/A
- 52 Week Low
- CUE $0.45
- GRWG $1.35
- 52 Week High
- CUE $2.58
- GRWG $3.38
- Technical
- Relative Strength Index (RSI)
- CUE 46.30
- GRWG 44.48
- Support Level
- CUE $1.20
- GRWG $1.35
- Resistance Level
- CUE $1.50
- GRWG $1.58
- Average True Range (ATR)
- CUE 0.12
- GRWG 0.07
- MACD
- CUE -0.02
- GRWG 0.01
- Stochastic Oscillator
- CUE 38.30
- GRWG 43.48
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.